ABO
Histo-blood group ABO system transferase
Also known as: BGAT_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- P16442
- Gene
- ABO
- Canonical length
- 354 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins
OverviewNCBI Gene
No narrative summary is available for ABO in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
354 residues, UniProt reviewed canonical sequence.
>P16442|ABO
1 MAEVLRTLAG KPKCHALRPM ILFLIMLVLV LFGYGVLSPR SLMPGSLERG FCMAVREPDH
61 LQRVSLPRMV YPQPKVLTPC RKDVLVVTPW LAPIVWEGTF NIDILNEQFR LQNTTIGLTV
121 FAIKKYVAFL KLFLETAEKH FMVGHRVHYY VFTDQPAAVP RVTLGTGRQL SVLEVRAYKR
181 WQDVSMRRME MISDFCERRF LSEVDYLVCV DVDMEFRDHV GVEILTPLFG TLHPGFYGSS
241 REAFTYERRP QSQAYIPKDE GDFYYLGGFF GGSVQEVQRL TRACHQAMMV DQANGIEAVW
301 HDESHLNKYL LRHKPTKVLS PEYLWDQQLL GWPAVLRKLR FTAVPKNHQA VRNPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ABO can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- ovary: 14 nTPM
- small intestine: 13 nTPM
- fallopian tube: 9 nTPM
- thyroid gland: 9 nTPM
- esophagus: 6.8 nTPM
- colon: 6.7 nTPM
Single-cell type
- renal collecting duct principal cells: 120 nCPM
- papillary tip epithelial cells: 113 nCPM
- renal connecting tubule cells: 102 nCPM
- renal collecting duct intercalated cells: 89 nCPM
- loop of henle epithelial cells: 62 nCPM
- proximal tubule cells: 59 nCPM
Immune cell
- eosinophil: 2.1 nTPM
- naive B-cell: 2.1 nTPM
- total PBMC: 1.5 nTPM
- basophil: 0.7 nTPM
- memory CD4 T-cell: 0.6 nTPM
- neutrophil: 0.6 nTPM
Brain region
- choroid plexus: 19 nTPM
- cerebral cortex: 17 nTPM
- hypothalamus: 15 nTPM
- white matter: 15 nTPM
- cerebellum: 14 nTPM
- basal ganglia: 14 nTPM
ReferencesPubMed · IEDB
Publications for ABO from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
11 publications
- Pathogenesis and mechanisms of antibody-mediated hemolysis.
2015 · Transfusion · RCR 3.3 · 71 citations - Prevention and management of platelet transfusion refractoriness.
1999 · Vox Sang · RCR 2.5 · 72 citations - Antibodies to histo-blood group substances A and B: agglutination titers, Ig class, and IgG subclasses in healthy persons of different age categories.
1991 · Transfusion · RCR 2 · 60 citations - ABO antibody and complement depletion by immunoadsorption combined with membrane filtration--a randomized, controlled, cross-over trial.
2014 · Nephrol Dial Transplant · RCR 1.7 · 39 citations - Flow cytometric analyses of the subclasses of red cell IgG antibodies.
1995 · Vox Sang · RCR 1 · 21 citations
Show 6 more
- Age dependency of ABO histo-blood group antibodies: reexamination of an old dogma.
1993 · Transfusion · RCR 0.6 · 23 citations - DNA extraction for short tandem repeat typing from mixed samples using anti-human leukocyte CD45 and ABO blood group antibodies.
2014 · Forensic Sci Int Genet · RCR 0.6 · 11 citations - 'AUTO'-anti-ABO antibodies after organ transplantation: a ciclosporin A related phenomenon?
1988 · Vox Sang · RCR 0.4 · 7 citations - Spectrotype analysis of human ABO antibodies: evidence for different clonal heterogeneity of IgM, IgG, and IgA antibody populations.
1996 · Vox Sang · RCR 0.2 · 7 citations - 125I anti-immunoglobulin binding assay for the detection and characterization of anti-platelet antibodies.
1980 · Hum Immunol · RCR 0.2 · 3 citations - Silent red blood cell autoantibodies: Are they naturally occurring or an effect of tolerance loss for a subsequent autoimmune process?
2020 · Autoimmunity · RCR 0 · 1 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- antigen binding
- manganese ion binding
- nucleotide binding
- fucosylgalactoside 3-alpha-galactosyltransferase activity
- glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ABO as an antibody target. Whether an autoantibody or antibody against ABO could matter depends on whether native ABO is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ABO is annotated as secreted, so native ABO circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ABO as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...